Mike Braun actually said...

My simple answer is that ALS patients are willing to accept greater risk because we know what is behind door number two.

The Promising Pathway Act is a commonsense step to give the FDA the flexibility it needs to serve Americans with these most trying diseases.

The time is not the right amount of time, and the children are being ignored in this and it shouldn't be that way.

Patients deserve a promising pathway at the FDA.